Pharmacokinetic study of orphenadrine using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS)

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jul 24;839(1-2):118-23. doi: 10.1016/j.jchromb.2006.02.056. Epub 2006 Apr 3.

Abstract

We developed and validated a simple, rapid, and accurate HPLC-MS/MS method with simple protein precipitation for the determination of orphenadrine. Injection-to-injection running time was 3 min with a retention time of orphenadrine of 1.1 min. The linear assay range was 1-200 ng/mL (r2 > 0.99). The intra- and inter-assay imprecisions were CV 0.6-4.2% and CV 1.6-6.1%, respectively. The accuracy, extraction recovery, specificity and stability were satisfactory. Using the measured plasma concentrations of orphenadrine in 24 healthy subjects, pharmacokinetic profiles of orphenadrine were evaluated (AUC(0-72,) 1565+/-731 ng h/mL, Cmax 82.8+/-26.2 ng/mL, Tmax 3.0+/-0.9 h, elimination half-life 25.8+/-10.3 h).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Chemical Precipitation
  • Chromatography, High Pressure Liquid
  • Drug Stability
  • Half-Life
  • Humans
  • Mass Spectrometry
  • Orphenadrine / blood*
  • Orphenadrine / chemistry
  • Orphenadrine / pharmacokinetics*
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Orphenadrine